Avadel Pharmaceuticals (AVDL) Current Assets: 2009-2021
Historic Current Assets for Avadel Pharmaceuticals (AVDL) over the last 13 years, with Dec 2021 value amounting to $192.5 million.
- Avadel Pharmaceuticals' Current Assets fell 44.99% to $113.2 million in Q3 2022 from the same period last year, while for Sep 2022 it was $113.2 million, marking a year-over-year decrease of 44.99%. This contributed to the annual value of $192.5 million for FY2021, which is 26.94% down from last year.
- According to the latest figures from FY2021, Avadel Pharmaceuticals' Current Assets is $192.5 million, which was down 26.94% from $263.5 million recorded in FY2020.
- In the past 5 years, Avadel Pharmaceuticals' Current Assets ranged from a high of $263.5 million in FY2020 and a low of $82.4 million during FY2019.
- Moreover, its 3-year median value for Current Assets was $192.5 million (2021), whereas its average is $179.4 million.
- Its Current Assets has fluctuated over the past 5 years, first slumped by 34.02% in 2019, then skyrocketed by 219.80% in 2020.
- Avadel Pharmaceuticals' Current Assets (Yearly) stood at $124.0 million in 2017, then rose by 0.71% to $124.9 million in 2018, then plummeted by 34.02% to $82.4 million in 2019, then soared by 219.80% to $263.5 million in 2020, then dropped by 26.94% to $192.5 million in 2021.